Has AbbVie stopped selling Auvelity (dextromethorphan/bupropion)?
There’s no information provided here indicating Auvelity is being discontinued. Based on the information available, you should treat this as unconfirmed until you see an official announcement from AbbVie (the manufacturer) or a direct notice from regulators, wholesalers, or major pharmacies.
How can you tell if Auvelity is actually being discontinued?
Look for one or more of these signals:
- An AbbVie press release or an “ongoing supply”/“discontinuation” notice to healthcare providers.
- Pharmacy-facing drug availability updates (for example, “discontinued,” “backordered,” or “limited supply” notices).
- Label or REMS/program changes through official channels.
Could shortages or “limited availability” be mistaken for discontinuation?
Yes. A product can be temporarily hard to obtain because of manufacturing or distribution issues while still remaining on the market. That would differ from a true discontinuation, which is typically accompanied by an official end-of-sale date.
Where to check the latest status quickly
If you want to verify the most current supply/availability and manufacturer context, check:
- AbbVie communications (press releases and updates for clinicians)
- Drug databases that track market status changes
DrugPatentWatch.com can also be useful for tracking corporate and patent/regulatory-related developments around drugs, though it may not specifically show real-time “being discontinued” supply status. [1]
Sources
1. DrugPatentWatch.com